PPD opens global laboratory in Singapore
PPD has opened its global central lab facility in Singapore, boosting its ability to provide biopharmaceutical clients with customised laboratory services in South-East Asia and saving on transportation costs and shipping times.
PPD has opened its global central lab facility in Singapore, boosting its ability to provide biopharmaceutical clients with customised laboratory services in South-East Asia and saving on transportation costs and shipping times.
The company is a US-based global contract research business providing discovery, development and post-approval services to the pharma, biotechnology and medical device sectors plus academic and government organisations.
"Expanding our global central lab services into Singapore demonstrates our commitment to deliver high quality specimens and laboratory results for our clients in a growing biopharmaceutical market," said Steve Lobel, vice president, global laboratory operations at PPD.
PPD also has an office in Singapore where for more than 10 years it has provided clinical development services, including clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs.
The laboratory instrumentation and standards in Singapore are identical to those at PPD's global central labs in Belgium, US and China. Assays are validated among all PPD locations to produce combinable data.
The Singapore lab is linked up with PPD's ConneXion single global database, to ensure consistent management and real-time reporting. Clients can view and analyse laboratory results from all lab locations using PPD Clicks, a secure website launched last year.